Product Images Hydralazine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Hydralazine Hydrochloride NDC 50228-183 by Sciegen Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (1,000 Tablets Bottle) - hht tabs 10 mg 1000s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (1,000 Tablets Bottle) - hht tabs 10 mg 1000s count

Each tablet of this medicine contains 10 mg of hydralazine hydrochloride. The recommended dosage is dependent on the information provided along with the prescription. It should be stored at temperatures ranging from 20°C to 25°C and needs to be kept away from children in a tight light-resistant container. This medicine is produced by ScieGen Pharmaceuticals in Hauppaugs, NY. The NDC number for this product is 50228-182-10 and comes in packs of 1,000 tablets that require a prescription.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (100 Tablets Bottle) - hht tabs 10 mg 100s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (100 Tablets Bottle) - hht tabs 10 mg 100s count

Each tablet contains 10 mg of hydralazine hydrochloride. It is advised to read the accompanying prescribing information and store the medication in a tight, light-resistant container with a child-resistant closure. The manufacturer is ScieGen Pharmaceticas, Inc, located in Hauppauge, NY. This medication should be kept out of the reach of children. It is used as a prescription medicine.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (1,000 Tablets Bottle) - hht tabs 100 mg 1000s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (1,000 Tablets Bottle) - hht tabs 100 mg 1000s count

Each tablet contains 100 mg of hydralazine hydrochloride, used to treat high blood pressure. The dosage should be followed as per the accompanying prescription. The medicine should be stored at room temperature and dispensed in a tightly sealed, light-resistant container to maintain its quality. The manufacturer of the medicine is ScieGen Pharmaceuticals Inc., and the tablets are available in a bottle of 1000 tablets. NDC 50228-185-10 is the National Drug Code (NDC) for the medicine. Keep the medicine out of children's reach.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (100 Tablets Bottle) - hht tabs 100 mg 100s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (100 Tablets Bottle) - hht tabs 100 mg 100s count

Each tablet of HydrALAZINE Hydrochloride contains 100 mg of hydralazine hydrochloride, USP. The usual dosage should be read from the accompanying prescribing information. The tablets should be stored within the temperature range of 20°C to 25°C (68°F to 77°F) and excursions are permitted up to 15°C to 30°C (59°F to 86°F) as indicated by USP Controlled Room Temperatures. Dispensing should be done in a tight light-resistant container as defined by the USP along with a child-resistant closure as required. Keep this and all medications away from the reach of children. Manufactured by ScieGen Pharmaceuticals, Inc. Hauppaugs, NY 11783. NDC code 50228-185-01. This medication requires a prescription.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (1,000 Tablets Bottle) - hht tabs 25 mg 1000s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (1,000 Tablets Bottle) - hht tabs 25 mg 1000s count

Each tablet of Hydralazine Hydrochloride contains 25 mg of the active ingredient. It is important to read the prescribing information before taking this medication. It should be stored in a tightly closed container, protected from light, at room temperature (20° to 25°C or 68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F) as specified in the USP. The container should also have a child-resistant closure. This medication should be kept out of reach of children. The manufacturer of this medication is SciaGen Pharmaceuticals, and it comes in a bottle of 1000 tablets. This medication requires a prescription to obtain.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (100 Tablets Bottle) - hht tabs 25 mg 100s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 25 mg (100 Tablets Bottle) - hht tabs 25 mg 100s count

Each tablet contains 25 mg of hydralazine hydrochloride, USP. It is important to read the accompanying prescribing information and keep the medication out of reach of children. The tablets should be stored between 20-25°C (88-77°F) with excursions permitted to 15-30°C (59-86°F). The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY and has an assigned National Drug Code (NDC) of 50228-183-01.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (1,000 Tablets Bottle) - hht tabs 50 mg 1000s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (1,000 Tablets Bottle) - hht tabs 50 mg 1000s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (100 Tablets Bottle) - hht tabs 50 mg 100s count

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (100 Tablets Bottle) - hht tabs 50 mg 100s count

Each tablet contains 50 mg of hydralazine hydrochloride, USP. It is a medication that requires a prescription and the usual dosage must be obtained from the accompanying prescribing information. It should be stored in a specific temperature range and in a tight, light-resistant container with a child-resistant closure. This medication should be kept out of reach of children. The manufacturer is ScieGen Pharmaceuticals, Inc. and it comes in a package containing 100 tablets.*

Chem structure - image 01

Chem structure - image 01

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.